Dr. A. V. Krishna Raju is a Principal Scientist at Laila Nutraceuticals R&D Center, India, with over two decades of expertise in natural products chemistry, phytopharmaceutical innovation, and botanical drug development. His work focuses on the isolation, standardization, and clinical validation of plant-based bioactives, particularly Boswellia serrata. He is best known for co-developing 5-Loxin® and Aflapin®, two patented Boswellia extracts with enhanced bioavailability and validated anti-inflammatory efficacy. These compounds have been studied extensively in preclinical and human trials, demonstrating significant improvements in osteoarthritis symptoms, including reductions in VAS, LFI, and WOMAC scores. Dr. Raju’s multidisciplinary approach spans phytochemistry, formulation, toxicology, and clinical research. He has contributed to multiple peer-reviewed publications and international patents and played a key role in achieving GRAS and novel food status for several botanical products. He is committed to bridging traditional herbal wisdom with modern science through evidence-based, globally compliant nutraceutical development.